Position in TBPH
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$807,263
+$160,365 QoQ
Shares Held
49,739
+43.9% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EntryPoint Capital, LLC holds $19,701,077 across 57 Biotechnology names. TBPH ranks #1 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TBPH |
Theravance Biopharma, Inc.
This page
|
49,739 | $807,263 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
3,922 | $783,027 | |
| 3 | ADMA |
Adma Biologics, Inc.
|
83,961 | $756,488 | |
| 4 | VCEL |
Vericel Corp
|
22,674 | $729,422 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
24,264 | $679,634 | |
| 6 | UPB |
Upstream Bio, Inc.
|
73,568 | $662,112 | |
| 7 | INCY |
Incyte Corp
|
6,483 | $610,179 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
26,119 | $547,193 |
All Filings in TBPH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $807,263 | 49,739 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $646,898 | 34,575 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $441,723 | 30,255 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $307,781 | 27,904 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||